Meet the industry innovators listed for The TRADE’s FinTech of the Year award, in partnership with Instinet. Appital, Capital Markets Gateway (CMG), Enfusion, Genesis Global, OpenGamma and Saphyre are fighting it out for the prize this year.
Phase 6 of the Uncleared Margin Rules has been implemented today, with the regulation having the biggest impact on the buy-side yet. Industry experts react to the deadline, giving insights on where we stand today.
Margin increases of more than 30%, as well as the UK base rates jumping from an historic low of 0.1% to 1.25%, are having a significant impact of the cost of funding for trading.
The FinTech plans to use the additional funding to expand its offering, including the launch of automated workflow solutions for the treasury management of asset managers.
Systematic investment manager Aspect Capital is expanding its use of OpenGamma’s analytics as it looks to trade new markets.
Collaboration between IHS Markit and OpenGamma aims to provide end-to-end support to clients for UMR compliance.
Market volatility sparked by the COVID-19 pandemic has resulted in a significant increase in prime brokers asking for more collateral from hedge funds.
OpenGamma’s analytics will help DRW improve its treasury trading functions to manage derivatives margin.
Despite the extension to comply with the final phase of the uncleared margin rules, major operational challenges remain for buy-side firms.
Pimco will use OpenGamma’s technology in a bid to reduce margin financing costs for derivatives trading.